September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Pathological Conversion of Regulatory T Cells Cause Disruption of Immune Privilege
Author Affiliations & Notes
  • Jing Hua
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • Takenori Inomata
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • William Stevenson
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • Tina Shiang
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • Yihe Chen
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • Jeffrey Bluestone
    Diabetes Center, University of California San Francisco, San Francisco, California, United States
  • Reza Dana
    Ophthalmology, Harvard Medical School, Cambridge, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Jing Hua, None; Takenori Inomata, None; William Stevenson, None; Tina Shiang, None; Yihe Chen, None; Jeffrey Bluestone, None; Reza Dana, None
  • Footnotes
    Support  NH Grant EY012963, NH Grant EY020889, the Richard Lindstrom research grant of Eye Bank Association of America, and NH Grant AI046643
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jing Hua, Takenori Inomata, William Stevenson, Tina Shiang, Yihe Chen, Jeffrey Bluestone, Reza Dana; Pathological Conversion of Regulatory T Cells Cause Disruption of Immune Privilege. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Disruption of immune privilege is associated with premature transplant rejection and autoimmunity, often leading to devastating inflammation and irreparable tissue damage. We examine the conversion of regulatory T cells (Tregs) into inflammatory cells (plasticity) in disruption of immune privilege in corneal transplantation model.

Methods : We utilized transgenic mice with a Foxp3-lineage reporter construct (Foxp3-GFPXR26-RFP) to trace the past and current expression of Foxp3 in Tregs; and measured the integrity of immune privilege by corneal graft survival rate. Adoptive transfers of isolated Treg subsets were carried out in healthy graft recipients vs. those with dry eye disease. The detailed phenotype of Foxp-3 lineage cells was analyzed using flow cytometry; their function was assessed using an ex vivo Treg suppression assay. ELISA and qPCR were used to assess cytokine expression associated with Treg plasticity.

Results : We found that inflammation in dry eye condition leads to high conversion of Foxp3+ Tregs to inflammatory exTregs, which no longer support immune privilege, leading to swift allograft rejection (55.6% vs. 11.1% survival rate, n=9, p=0.019 Log-Rank). The Treg suppression assay showed Tregs from dry eye recipients lost significant suppressive function at day 21 (82.3% in healthy control vs. 56.8% in dry eye, n=3-6, **P<0.01). Adoptive transfer of Tregs (CD4+CD25+) from naïve BALB/c mice recipients with dry eye led to dramatic increase of corneal graft survival (0% [non-Treg] vs. 50% [Treg] n=10; χ2=11.25, p=0.0008, Log-Rank). Adoptive transfer of Treg subsets demonstrated that the peripherally induced neuropilin-1 negative Tregs (pTreg) are the key regulators of allo-tolerance, but are highly susceptible to environmental cues including interleukin-6 (IL-6) and IL-23, which promote their conversion to pathogenic exTregs. Neutralization of IL-6 and IL-23 with simultaneous transfer of isolated pTregs demonstrated significant less conversion into inflammatory exTregs, and successful rescue of corneal grafts (90% survival vs. 50% control thymic Tregs; n=10, χ2=4.503, p=0.0338, Log-Rank) in dry eye recipients (10% initial survival).

Conclusions : These results provide the first evidence that disruption of immune privilege is mediated by pathological conversion of Tregs. Preventing the pathological conversion of pTregs may be a novel strategy to ameliorate graft survival.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×